# EDGAR Filing Document

**Accession Number:** 0001769628
**File Stem:** 0001769628-25-000116
**Filing Date:** 2025-12
**Character Count:** 12369
**Document Hash:** 5e7b03f94e3db443ee284c59ec51df96
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001769628-25-000116.hdr.sgml**: 20251217

**ACCESSION NUMBER**: 0001769628-25-000116

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20251215

**FILED AS OF DATE**: 20251217

**DATE AS OF CHANGE**: 20251217

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** McBee Brannin
- **CENTRAL INDEX KEY:** 0002058103

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42563
- **FILM NUMBER:** 251581019

**MAIL ADDRESS:**
- **STREET 1:** C/O COREWEAVE, INC.
- **STREET 2:** 290 WEST MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CoreWeave, Inc.
- **CENTRAL INDEX KEY:** 0001769628
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 823060021
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 290 W. MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039
- **BUSINESS PHONE:** (973) 270-9737

**MAIL ADDRESS:**
- **STREET 1:** 290 W. MT. PLEASANT AVENUE, SUITE 4100
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Atlantic Crypto Corp
- **DATE OF NAME CHANGE:** 20190304

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[x] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>McBee Brannin<br><sub>(Last) (First) (Middle)</sub><br>C/O COREWEAVE, INC.<br>290 WEST MT. PLEASANT AVENUE, SUITE 4100<br><sub>(Street)</sub><br>LIVINGSTON, NJ 07039<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-15 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Development Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CoreWeave, Inc. [ CRWV ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 403 | D | 72.5224<sup>(2)</sup> | 597 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 445 | D | 73.7287<sup>(4)</sup> | 152 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 61 | D | 74.5231<sup>(5)</sup> | 91 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 37 | D | 76.3654<sup>(6)</sup> | 54 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 36 | D | 78.855<sup>(7)</sup> | 18 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 18 | D | $79.69 | 0 | I | Canis Major 2025 Family Trust LLC<sup>(3)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 403 | D | 72.5228<sup>(2)</sup> | 597 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 445 | D | 73.7293<sup>(4)</sup> | 152 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 61 | D | 74.5231<sup>(5)</sup> | 91 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 36 | D | 76.355<sup>(6)</sup> | 55 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 37 | D | 78.8495<sup>(7)</sup> | 18 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 18 | D | $79.69 | 0 | I | Canis Minor 2025 Family Trust LLC<sup>(8)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 10140 | D | 72.4923<sup>(9)</sup> | 14860 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 10077 | D | 73.6677<sup>(11)</sup> | 4783 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 2852 | D | 74.3739<sup>(12)</sup> | 1931 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 501 | D | 75.5933<sup>(13)</sup> | 1430 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 376 | D | 76.573<sup>(14)</sup> | 1054 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 496 | D | 78.2976<sup>(15)</sup> | 558 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 558 | D | 79.382<sup>(16)</sup> | 0 | I | Canis Major 2025 GRAT<sup>(10)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 3381 | D | 72.4923<sup>(9)</sup> | 4954 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 3360 | D | 73.6678<sup>(11)</sup> | 1594 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 950 | D | 74.3737<sup>(12)</sup> | 644 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 168 | D | 75.5939<sup>(13)</sup> | 476 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 125 | D | 76.5765<sup>(14)</sup> | 351 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 165 | D | 78.2982<sup>(15)</sup> | 186 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |
| Class A Common Stock | 2025-12-15 |  | S<sup>(1)</sup> |  | 186 | D | 79.3809<sup>(16)</sup> | 0 | I | Canis Minor 2025 GRAT<sup>(17)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 2, 2025.

(2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.19 to $73.01, inclusive.

(3) The reported securities are directly held by the Canis Major 2025 Family Trust LLC, of which the reporting person serves as manager.

(4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.16, inclusive.

(5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.30 to $74.94, inclusive.

(6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.97 to $76.74, inclusive.

(7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.65 to $79.06, inclusive.

(8) The reported securities are directly held by the Canis Minor 2025 Family Trust LLC, of which the reporting person serves as manager.

(9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.08 to $73.07, inclusive.

(10) The reported securities are directly held by the Canis Major 2025 GRAT, of which the reporting person is the sole trustee and beneficiary.

(11) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.08 to $74.07, inclusive.

(12) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.08 to $75.03, inclusive.

(13) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.08 to $76.06, inclusive.

(14) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.10 to $77.07, inclusive.

(15) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.02 to $78.80, inclusive.

(16) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.11 to $79.69, inclusive.

(17) The reported securities are directly held by the Canis Minor 2025 GRAT, of which the reporting person's spouse is the sole beneficiary and trustee.

**Remarks:**
This Form 4 is Part 2 of 3 for this reporting person. Transactions by the reporting person reported on Table I are continued on Part 3.

**Signature:** /s/ Nisha Antony, as Attorney-in-Fact  
**Date:** 2025-12-17

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**